Table 2.
Experimental Group |
Control Group |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline |
Time 2 |
Time 3 |
Baseline |
Time 2 |
Time 3 |
|||||||
Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
Caregiver | ||||||||||||
Depressive symptomatologya | 10.8 | 9.2 | 9.7 | 9.7 | 7.7 | 9.1 | 11.3 | 10.2 | 7.4 | 8.4 | 8.1 | 10.1 |
Masteryb | 26.8 | 4.8 | 27.0 | 4.8 | 28.4 | 4.1 | 26.6 | 4.0 | 27.6 | 4.5 | 27.9 | 4.5 |
Symptom assistance | 3.4 | 2.7 | 2.7 | 2.4 | 1.3 | 1.7 | 3.6 | 2.5 | 2.4 | 2.5 | 1.5 | 1.8 |
Social functioningc | 81.4 | 21.9 | 82.0 | 23.4 | 89.4 | 17.6 | 78.3 | 23.9 | 86.2 | 22.3 | 84.7 | 24.0 |
Patient | ||||||||||||
Depressive symptomatologya | 12.2 | 9.0 | 10.6 | 8.9 | 6.6 | 7.7 | 13.6 | 9.0 | 12.7 | 9.2 | 9.9 | 9.2 |
Symptom severityd | 29.0 | 21.7 | 24.5 | 16.6 | 15.6 | 13.6 | 27.0 | 17.2 | 29.4 | 18.3 | 20.6 | 17.3 |
Physical functioningc | 65.8 | 28.6 | 66.9 | 24.9 | 77.2 | 22.9 | 63.2 | 30.0 | 62.0 | 28.0 | 67.0 | 30.2 |
Social functioningc | 57.0 | 28.3 | 64.9 | 29.8 | 80.0 | 26.8 | 57.2 | 30.0 | 59.5 | 30.9 | 69.8 | 30.4 |
Chemotherapy status | n | % | n | % | n | % | n | % | n | % | n | % |
Yes | 118 | 100.0 | 83 | 70.9 | 57 | 48.7 | 119 | 100.0 | 92 | 78.0 | 57 | 48.3 |
No | 0 | 0.0 | 34 | 29.1 | 60 | 51.3 | 0 | 0.0 | 26 | 22.0 | 61 | 51.7 |
Scale 0–60.
Scale 7–35.
Scale 0–100.
Scale 0–150.